Alnylam Pharmaceuticals, Inc.

ING GROEP NV ALNY
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/11/2026
Shares
1,289
Value ($000)
426
Weight
0.0%
2014 Q1 - 2026 Q1 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).